Summary

The Coronary Heart Disease Diagnostic Imaging Devices Market is valued at US$ 2.19 billion in 2025 and is projected to grow at a CAGR of 5.4% to reach US$ 3.52 billion by 2034.

Overview:
The coronary heart disease diagnostic imaging devices market consists of imaging systems and associated software used to identify, evaluate and monitor coronary artery disease (CAD) - i.e., atherosclerotic narrowing of coronary arteries - and related ischemic heart conditions. Devices span modalities such as computed tomography (CT) (including coronary CTA), magnetic resonance imaging (MRI), nuclear medicine (PET, SPECT myocardial perfusion), X‑ray/fluoroscopy (coronary angiography imaging), and ultrasound (echocardiography with advanced coronary flow/strain imaging). Key applications include initial diagnosis of suspected CAD, assessment of coronary plaque and stenosis in symptomatic or at‑risk patients, stratification of risk and planning of interventional/cardiac‑surgery treatment, and post‑procedure monitoring (stent/CTO assessment, graft patency). Recent trends include increased use of non‑invasive coronary CTA in lieu of invasive angiography, integration of AI/ML for lesion detection and plaque characterisation, hybrid imaging (PET/CT, PET/MR) for functional plus anatomic assessment, portable/point‑of‑care imaging for remote or resource‑limited settings, and adoption of advanced detector technologies (e.g., photon‑counting CT) for lower radiation dose and higher resolution. Growth drivers include the global rise in CAD prevalence (driven by aging populations, diabetes, obesity and sedentary lifestyles), increasing awareness and screening initiatives for heart disease, expansions in healthcare infrastructure (especially in emerging economies), and the push toward early detection to reduce downstream invasive interventions and cost of care. From a competitive standpoint the market involves large imaging OEMs (CT/MR/nuclear systems) as well as specialist cardiac imaging software providers and service networks; success hinges on modality performance (resolution, speed, radiation/contrast dosage), integration with cardiology workflow and reporting, reimbursement environment (for cardiac imaging), and ability to support remote/digital diagnostics. Additional market considerations: high capital equipment cost and infrastructure requirements can delay adoption in lower‑income settings; operator training and workflow integration remain key; accuracy and clinical validation of new imaging modalities (especially AI‑driven) are becoming differentiators.

Key Insights:
• Non invasive coronary CTA is gaining share
As physicians and payers increasingly favour non invasive diagnosis, coronary CT angiography (CTA) is fast emerging as a first line imaging modality for suspected CAD, reducing reliance on invasive angiography for low to moderate risk patients.

• Functional + anatomical imaging synergy
Combining anatomical imaging (CT/MR) with functional assessment (PET, SPECT, MRI perfusion) offers more comprehensive CAD evaluation, improving diagnostic accuracy and influencing modality purchasing decisions.

• AI and advanced analytics drive differentiation
Software algorithms for plaque quantification, stenosis detection, motion correction, and risk prediction are adding value, enabling faster reading, standardised reporting and potentially improved outcomes, thereby giving vendors competitive edge.

• Emerging markets offer growth frontiers
Regions such as Asia Pacific and Latin America are witnessing expansion of cardiac imaging infrastructure, improving affordability of advanced systems, and a large undiagnosed CAD burden - making them high growth territories for diagnostic imaging devices.

• Radiation dose and contrast minimisation matter
Patient and clinician concerns over radiation exposure (especially in younger cohorts) and contrast nephropathy are pushing demand for low dose CT, MRI alternatives and improved detector technologies - a factor shaping device selection.

• Workflow and integration with cardiology ecosystem
Devices that integrate well into cardiology labs (reporting systems, PACS, catheterisation suites), enable remote or cloud based reporting and support hybrid operating rooms appeal more strongly to hospital systems looking for end to end solutions.

• Reimbursement, regulatory and guideline shifts influence uptake
As professional society guidelines evolve (endorsing CTA earlier) and payers recognise value of early CAD detection, reimbursement becomes a major enabler. Conversely, lack of clear reimbursement or regulatory hurdles can slow uptake.

• High end segmentation premium and cost barriers
Advanced imaging devices remain high cost capital purchases; hospitals and imaging centres must justify return on investment via case volume, utilisation rates and downstream revenue. This cost barrier can limit penetration in smaller or rural facilities.

• Retrofit and upgrade opportunities exist
Many cardiac imaging labs still use older equipment; opportunity exists for retrofit (software upgrades, detector replacements) or modular additions rather than full system replacement, providing quicker ROI for vendors and buyers.

• Service, training and after sales support are differentiators
Given complexity of cardiac imaging (motion artefact, contrast protocols, reporting accuracy), device manufacturers and distributors with strong training, support, service network and remote diagnostics capability have a competitive advantage.

Regional Analysis:
North America
In North America, the market is advanced and relatively mature, driven by high CAD prevalence, significant healthcare spending, and widespread adoption of advanced cardiac imaging modalities. Hospitals and specialised cardiac centres invest in best‑in‑class CT/MR/nuclear systems and AI‑enabled software, supported by reimbursement frameworks and guidelines favouring early detection. Growth is robust but incremental; premium devices dominate, with retrofit/upgrade strategies common.

Europe
Europe’s market is stable, with moderate growth spurred by ageing populations, preventive cardiology initiatives and uptake of non‑invasive imaging. Key factors include stringent regulatory frameworks, multipayer healthcare systems and cost‑containment pressures. Hospitals favour devices that deliver high throughput, lower operating cost and demonstrable clinical value. Emerging countries in Eastern Europe are catching up, offering incremental expansion.

Asia‑Pacific
Asia‑Pacific represents the fastest‑growing market segment, driven by large undiagnosed CAD populations, rapid infrastructure build‑out (new hospitals, imaging centres), rising healthcare expenditure and growing middle‑class health awareness. Many countries deploy CT/MR/nuclear imaging at scale; price sensitivity is higher, so vendors offering cost‑effective, modular or mobile imaging solutions stand to gain. Tele‑cardiology and remote imaging are expanding in rural/suburban markets.

Middle East & Africa
In the Middle East & Africa, opportunities are tied to growing healthcare investment, expansion of private cardiology hospitals and rising CAD incidence. However, uptake is moderated by cost constraints, limited specialist workforce, and variable infrastructure. Stand‑alone imaging centres, mobile imaging units, and partnerships/joint‑ventures with global vendors are common entry strategies.

South & Central America
In South & Central America, the market is evolving. Growth is supported by increasing cardiac disease burden, hospital infrastructure expansion and rising private‑sector investment. However, challenges include lower per‑capita spending, varied reimbursement, and logistical constraints. Vendors that provide flexible financing, leasing models and local service support will be more successful in gaining share

ページTOPに戻る

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Global Coronary Heart Disease Diagnostic Imaging Devices Market Summary, 2025
2.1 Coronary Heart Disease Diagnostic Imaging Devices Industry Overview
2.1.1 Global Coronary Heart Disease Diagnostic Imaging Devices Market Revenues (In US$ billion)
2.2 Coronary Heart Disease Diagnostic Imaging Devices Market Scope
2.3 Research Methodology

3. Coronary Heart Disease Diagnostic Imaging Devices Market Insights, 2024-2034
3.1 Coronary Heart Disease Diagnostic Imaging Devices Market Drivers
3.2 Coronary Heart Disease Diagnostic Imaging Devices Market Restraints
3.3 Coronary Heart Disease Diagnostic Imaging Devices Market Opportunities
3.4 Coronary Heart Disease Diagnostic Imaging Devices Market Challenges
3.5 Tariff Impact on Global Coronary Heart Disease Diagnostic Imaging Devices Supply Chain Patterns

4. Coronary Heart Disease Diagnostic Imaging Devices Market Analytics
4.1 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, Key Products, 2025 Vs 2034
4.2 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, Dominant Applications, 2025 Vs 2034
4.3 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, Leading End Uses, 2025 Vs 2034
4.4 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, High Growth Countries, 2025 Vs 2034
4.5 Five Forces Analysis for Global Coronary Heart Disease Diagnostic Imaging Devices Market
4.5.1 Coronary Heart Disease Diagnostic Imaging Devices Industry Attractiveness Index, 2025
4.5.2 Coronary Heart Disease Diagnostic Imaging Devices Supplier Intelligence
4.5.3 Coronary Heart Disease Diagnostic Imaging Devices Buyer Intelligence
4.5.4 Coronary Heart Disease Diagnostic Imaging Devices Competition Intelligence
4.5.5 Coronary Heart Disease Diagnostic Imaging Devices Product Alternatives and Substitutes Intelligence
4.5.6 Coronary Heart Disease Diagnostic Imaging Devices Market Entry Intelligence

5. Global Coronary Heart Disease Diagnostic Imaging Devices Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
5.1 World Coronary Heart Disease Diagnostic Imaging Devices Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
5.1 Global Coronary Heart Disease Diagnostic Imaging Devices Sales Outlook and CAGR Growth By Modality, 2024- 2034 ($ billion)
5.2 Global Coronary Heart Disease Diagnostic Imaging Devices Sales Outlook and CAGR Growth By End-User, 2024- 2034 ($ billion)
5.3 Global Coronary Heart Disease Diagnostic Imaging Devices Sales Outlook and CAGR Growth By Segmentation3, 2024- 2034 ($ billion)
5.4 Global Coronary Heart Disease Diagnostic Imaging Devices Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

6. Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Industry Statistics – Market Size, Share, Competition and Outlook
6.1 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Insights, 2025
6.2 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast By Modality, 2024- 2034 (USD billion)
6.3 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast By End-User, 2024- 2034 (USD billion)
6.4 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast By Segmentation3, 2024- 2034 (USD billion)
6.5 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast by Country, 2024- 2034 (USD billion)
6.5.1 China Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034
6.5.2 India Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034
6.5.3 Japan Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034
6.5.4 Australia Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034

7. Europe Coronary Heart Disease Diagnostic Imaging Devices Market Data, Penetration, and Business Prospects to 2034
7.1 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Key Findings, 2025
7.2 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown By Modality, 2024- 2034 (USD billion)
7.3 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown By End-User, 2024- 2034 (USD billion)
7.4 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown By Segmentation3, 2024- 2034 (USD billion)
7.5 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
7.5.1 Germany Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
7.5.2 United Kingdom Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
7.5.2 France Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
7.5.2 Italy Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
7.5.2 Spain Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034

8. North America Coronary Heart Disease Diagnostic Imaging Devices Market Size, Growth Trends, and Future Prospects to 2034
8.1 North America Snapshot, 2025
8.2 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook By Modality, 2024- 2034 ($ billion)
8.3 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook By End-User, 2024- 2034 ($ billion)
8.4 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook By Segmentation3, 2024- 2034 ($ billion)
8.5 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
8.5.1 United States Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Canada Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Mexico Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share, Growth Trends and Forecast, 2024- 2034

9. South and Central America Coronary Heart Disease Diagnostic Imaging Devices Market Drivers, Challenges, and Future Prospects
9.1 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Data, 2025
9.2 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future By Modality, 2024- 2034 ($ billion)
9.3 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future By End-User, 2024- 2034 ($ billion)
9.4 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future By Segmentation3, 2024- 2034 ($ billion)
9.5 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future by Country, 2024- 2034 ($ billion)
9.5.1 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share and Opportunities to 2034
9.5.2 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share and Opportunities to 2034

10. Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2025
10.2 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics By Modality, 2024- 2034 (USD billion)
10.3 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics By End-User, 2024- 2034 (USD billion)
10.4 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics By Segmentation3, 2024- 2034 (USD billion)
10.5 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics by Country, 2024- 2034 (USD billion)
10.5.1 Middle East Coronary Heart Disease Diagnostic Imaging Devices Market Value, Trends, Growth Forecasts to 2034
10.5.2 Africa Coronary Heart Disease Diagnostic Imaging Devices Market Value, Trends, Growth Forecasts to 2034

11. Coronary Heart Disease Diagnostic Imaging Devices Market Structure and Competitive Landscape
11.1 Key Companies in Coronary Heart Disease Diagnostic Imaging Devices Industry
11.2 Coronary Heart Disease Diagnostic Imaging Devices Business Overview
11.3 Coronary Heart Disease Diagnostic Imaging Devices Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis

12 Appendix
12.1 Global Coronary Heart Disease Diagnostic Imaging Devices Market Volume (Tons)
12.1 Global Coronary Heart Disease Diagnostic Imaging Devices Trade and Price Analysis
12.2 Coronary Heart Disease Diagnostic Imaging Devices Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Coronary Heart Disease Diagnostic Imaging Devices Industry Report Sources and Methodology